Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The study is a first-in-human Phase 1/2a randomized, double-blind, placebo-controlled trial to assess the clinical safety and efficacy of VRELysin in healthy and VRE-colonized adults.
Epistemonikos ID: 260cee53682f51c1fbacf37d2291c27e04c0c99c
First added on: Feb 19, 2024